Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Leprosy Treatment Companies

ID: MRFR/HC/2575-HCR
200 Pages
Satyendra Maurya
Last Updated: February 16, 2025
Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. The treatment of leprosy typically involves multidrug therapy to effectively eliminate the bacteria and prevent the progression of the disease.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Leprosy Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.43%
2024 Market Size$ 0.75 Billion
2025 Market Size$ 0.78 Billion
2035 Market Size$ 1.21 Billion
Key Players
Novartis
Sanofi
GlaxoSmithKline
Bristol-Myers Squibb
AstraZeneca
Merck & Co.
Opportunities
  • Rising Awareness and Advocacy
  • Rising Incidence of Leprosy Cases
  • Government Initiatives and Funding

Top Industry Leaders in the Leprosy Treatment Market

Leprosy treatment Key Companies
ย 
Latest Leprosy treatment Companies Update

GlaxoSmithKline (GSK) longstanding anti-leprosy drug clofazimine remains a key component of MDT regimens and GSK actively participates in global leprosy control initiatives.

Novartis Continues to provide their anti-leprosy drug rifampicin through various programs and partnerships, contributing to treatment access in affected regions.

Bayer Collaborates with the World Health Organization and other partners on leprosy research and development initiatives, including exploring new drug combinations and diagnostics.

Sandoz (Novartis) Offers generic versions of essential anti-leprosy drugs like clofazimine and dapsone, contributing to affordability and wider access to treatment in resource-limited settings.

Institute for One World Health (IOWH) Develops and advocates for affordable, readily available, and user-friendly treatment options like fixed-dose combinations for leprosy, simplifying administration and potentially improving adherence.

List of Leprosy Treatment Key Companies in the Market

  • Glaxo Smithcline
  • Systopic Laboratories Pvt. Ltd.
  • Cadila Pharmaceuticals
  • Acme Pharmaceuticals
  • Macleods Pharmaceuticals
  • Novartis International AG
  • Astra Zeneca
  • Lark Laboratories Ltd